Drawing for ZOSTRAXIN

USPTO serial 87507388

ZOSTRAXIN

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
CROWLEY, PAUL
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZOSTRAXIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

YOON S. HAM HAUPTMAN HAM, LLP2318 MILL ROADSUITE 1400ALEXANDRIA, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005VaccinesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 21, 2017MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Dec 21, 2017ABN5ABANDONMENT - AFTER PUBLICATION—
Dec 15, 2017EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Nov 20, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 18, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 27, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2017DOCKASSIGNED TO EXAMINER—
Jul 5, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 30, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance